These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 922752)

  • 1. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; LoBuglio A; McCracken J; Pugh R
    Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT; Al-Sarraf M; Hewlett JS
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
    Maki RG; Kraft AS; Scheu K; Yamada J; Wadler S; Antonescu CR; Wright JJ; Schwartz GK
    Cancer; 2005 Apr; 103(7):1431-8. PubMed ID: 15739208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH; Montella D; Rosenbaum C; Schwen M
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
    Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Bruckner HW; Lokich JJ; Stablein DM
    Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of epirubicin in advanced soft tissue sarcoma.
    Chevallier B; Montcuquet P; Fachini T; Nguyen Bui B; Kerbrat P; Bastit P; Vo Van ML
    Bull Cancer; 1990; 77(10):991-5. PubMed ID: 2249019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas.
    Patel SR; Beach J; Papadopoulos N; Burgess MA; Trent J; Jenkins J; Benjamin RS
    Cancer; 2003 Jun; 97(11):2848-52. PubMed ID: 12767099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.
    Chugh R; Dunn R; Zalupski MM; Biermann JS; Sondak VK; Mace JR; Leu KM; Chandler WF; Baker LH
    J Clin Oncol; 2005 May; 23(15):3597-604. PubMed ID: 15908670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
    Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
    Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of pentamethylmelamine.
    Ajani JA; Cabanillas FF; Bodey GP
    Cancer Treat Rep; 1982 May; 66(5):1227-8. PubMed ID: 6805950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.